Preclinical Evaluation of 99mTc Direct Labeling ZHER2:V2 for HER2 Positive Tumors Imaging

Oncology Letters - Greece
doi 10.3892/ol.2018.9279
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Three Methods for 18F Labeling of the HER2-Binding Affibody Molecule ZHER2:2891 Including Preclinical Assessment

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2013English

Pre-Clinical Evaluation of [111In]-Benzyl-Dota-Zher2:342, a Potential Agent for Imaging of HER2 Expression in Malignant Tumors

International Journal of Molecular Medicine
MedicineGenetics
2007English

All HER2-Positive Tumors Are Not Created Equal

Annals of Surgical Oncology
OncologySurgery
2017English

Comparative Evaluation of Radioiodine and Technetium-Labeled DARPin 9_29 for Radionuclide Molecular Imaging of HER2 Expression in Malignant Tumors

Contrast Media and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2018English

Novel Arginine-Containing Macrocyclic MMP Inhibitors: Synthesis, 99mTc-Labeling, and Evaluation

Scientific Reports
Multidisciplinary
2018English

Design, Synthesis and Labeling of Tripeptide Derivatives With 99mTc as Hypoxia Imaging Agents

Iranian South Medical Journal
2019English

In Vitro Evaluation of a Specific Radiochemical Compound Based on 99mTc-Labeled DARPinG3 for Radionuclide Imaging of Tumors Overexpressing Her-2/Neu

2017English

Clinically Applicable Magnetic-Labeling of Natural Killer Cells for MRI of Transcatheter Delivery to Liver Tumors: Preclinical Validation for Clinical Translation

Nanomedicine
DevelopmentMaterials ScienceNanoscienceMedicineBioengineeringNanotechnologyBiomedical Engineering
2015English

In VivoandIn VitroStudies on Renal Uptake of Radiolabeled Affibody Molecules for Imaging of HER2 Expression in Tumors

Cancer Biotherapy and Radiopharmaceuticals
Nuclear MedicineRadiologyPharmacologyCancer ResearchOncologyImagingMedicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy